#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Dementia Alzheimer's type Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Short stature Duchenne muscular dystrophy gene carrier Cataract Haemophilia Thrombotic thrombocytopenic purpura Chronic inflammatory demyelinating polyradiculoneuropathy Ovarian cancer Malformation venous Heritable pulmonary arterial hypertension Interstitial lung disease Renal cancer metastatic Erdheim-Chester disease Acute graft versus host disease in skin Malignant peritoneal neoplasm Autoimmune hepatitis More trials…

    Learn about Rare Diseases

    Netherton’s syndrome – Treatment Inclusion body myositis Mantle cell lymphoma refractory – Diagnostics Angiosarcoma metastatic Congenital hypotransferrinaemia Cystic fibrosis – Basic Information Familial amyotrophic lateral sclerosis – Diagnostics Biotinidase deficiency – Trials in Disease Combined immunodeficiency Fragile X syndrome – Life with Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    177Lu-Rhpsma-10.1 Piperacillin Cefotaxime Sodium Ammonium Chloride Human Fibrinogen ALE.P02 Nadroparin Calcium R-Azasetron Besilate Metoclopramide Hydrochloride Bi 3720931 Lacosamide Tramadol Hydrochloride Ptg-Carcik-Cd19 Pseudoephedrine Hydrochloride Regn9933 TIFCEMALIMAB Tecaginlimab 19Cp02 Fosaprepitant ALLERGEN EXTRACTS More therapies…

    Learn about Your Condition

    Gastric cancer recurrent Diabetic foot infection Status epilepticus Haemofiltration Fibrosarcoma metastatic Renal cancer Spinal cord injury cervical Menopause Erosive oesophagitis Eye pain Dengue fever Bronchostenosis Splenic marginal zone lymphoma Retroperitoneal cancer Hereditary angioedema More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Neoplasm

  • Study on the Safety and Effects of XL092 with Nivolumab, Ipilimumab, and Relatlimab for Patients with Advanced Solid Tumors

    Recruiting

    1 1 1 1
    Investigated Drugs:
    • Relatlimab
    • Ipilimumab
    • N-(4-Fluorophenyl)-N-(4-((7-Methoxy-6-(Methylcarbamoyl)Quinolin-4- Yl)Oxy)Phenyl)Cyclopropane-1,1-Dicarboxamide
    Austria Belgium France Germany Italy Poland +1

  • Study of Zenocutuzumab for Patients with Solid Tumors with NRG1 Fusion

    Recruiting

    2 1 1
    Investigated Diseases:
    • Neoplasm
    Investigated Drugs:
    • Zenocutuzumab
    Austria Belgium Denmark France Germany Italy +4

  • Study on the Safety and Tolerability of D3S-001 Alone or with Drug Combination in Adults with Advanced Solid Tumors with KRAS p.G12C Mutation

    Recruiting

    2 1 1 1
    Investigated Drugs:
    • 2-((S)-4-((S)-7-(3-Amino-2-Fluoro-5-Methyl-6-(Trifluoromethyl)Phenyl)-2-(((2R,7As)-2-Fluorotetrahydro-1H-Pyrrolizin-7A(5H)-Yl)Methoxy)-7,8-Dihydro-5H-Pyrano(4,3-D)Pyrimidin-4-Yl)-1-(2-Fluoroacryloyl)Piperazin-2-Yl)Acetonitrile
    • Pemetrexed Disodium
    • Carboplatin
    France Germany Italy Spain

  • Study of Tulmimetostat (CPI-0209) for Patients with Advanced Solid Tumors and Lymphomas

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Mesothelioma malignant
    • Lymphoma
    • Endometrial cancer
    Investigated Drugs:
    • Tulmimetostat
    • Enzalutamide
    France Italy Poland Spain

  • Study of AZD3470 alone and in combination with other cancer drugs for patients with advanced solid tumors that are MTAP deficient

    Recruiting

    1 1 1 1
    Investigated Diseases:
    • Neoplasm
    Investigated Drugs:
    • Azd3470
    • Dextromethorphan Hydrobromide
    • Midazolam
    France The Netherlands Spain

  • Study of PC14586 for Patients with Advanced Solid Tumors with a Specific TP53 Mutation

    Recruiting

    2 1 1
    Investigated Diseases:
    • Lung neoplasm malignant
    • Endometrial cancer
    • Ovarian cancer
    Investigated Drugs:
    • Pc14586
    France Germany Italy Spain
Previous Page
1 … 6 7 8 9 10 … 25
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!